The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer

Medicine
Nan-Nan BianGuo-Sheng Feng

Abstract

Numerous studies have shown that the blood of cancer patients are generally in hypercoagulable statement. The aim of the present research is to study the relationships of plasma fibrinogen (Fbg) levels with clinicopathological stages (CS) and tumor markers of non-small cell lung cancer (NSCLC).Baseline information, plasma Fbg levels, CS, and expression level of tumor markers were collected from medical records retrospectively. Unitary linear regression was used to analyze the relationships between continuous variables and Fbg, and multiple linear regression was used to analyze the relationships between categorical variables and Fbg. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Version 4) for NSCLC were adopted to evaluate CS.A total of 652 NSCLC patients were included. Compared with the females, male patients had higher mean plasma Fbg levels (P < .001). The later the N stages (P = .002), M stages (P = .002), and CS (P = .001) were, the higher the average plasma Fbg levels were. The levels of squamous cell carcinoma antigen (P = .001), carbohydrate antigen 125 (P = .041), and neuron-specific enolase (P < .001) were positively correlated with plasma Fbg concentration. The plasma level of Fbg in...Continue Reading

References

Dec 1, 1988·Thorax·R MilroyS W Banham
Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BuccheriC Zuliani
Mar 7, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·S J PaveyN A Marsh
Jun 13, 2001·The European Respiratory Journal·D FerrignoI Ricca
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 1, 2012·Haematologica·Cihan AyIngrid Pabinger
Dec 4, 2012·Respiratory Medicine·Faruk TasDerya Duranyildiz
Feb 8, 2013·International Journal of Cancer. Journal International Du Cancer·Liming ShengDan Su
Jun 19, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wei-Xin Zhao, Jian-feng Luo
Apr 23, 2014·Journal of Korean Medical Science·Kyung Hee KimSeok-Chul Yang
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 18, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·L-R ZhuX-P Tang
Oct 21, 2015·Cancer Biomarkers : Section a of Disease Markers·Amanda Souza AraújoEanes Delgado Barros Pereira
Mar 10, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerMiranda Hughes
May 2, 2017·Clinica Chimica Acta; International Journal of Clinical Chemistry·Weigang WangJiexian Jing
May 16, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Haihong JiangZhijian Liang
Jun 13, 2017·Technology in Cancer Research & Treatment·Xianming FeiWufeng Yuan
Nov 21, 2017·Annals of Translational Medicine·Xuqin JiangXiaojuan Chen
Apr 14, 2018·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shuaishuai ChenShiyong Chen
May 8, 2018·Journal of Clinical Laboratory Analysis·Xiaochuan WangGuobao Zheng
Jun 1, 2018·Thoracic Cancer·Kentaro NakanoYasutsugu Fukushima

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.